Edistride 10mg dapagliflozin

Edistride is a prescription medication containing the active substance dapagliflozin, primarily used to treat type 2 diabetes, heart failure, and chronic kidney disease. It belongs to the class of SGLT2 inhibitors.

The brand is part of AstraZeneca's portfolio. While AstraZeneca is a British-Swedish multinational, the production of dapagliflozin-based products occurs across global supply chains, including manufacturing sites in the United Kingdom, Puerto Rico, and various European countries. The specific local variant shown is marketed in Spain, where AstraZeneca Farmacéutica Spain operates as the local subsidiary distributor.